Literature DB >> 8313380

Stimulatory effects of immune reactions upon the growths of untransplanted tumors.

R T Prehn1.   

Abstract

The accumulated literature suggests that altering the immune capacities of animals or humans seldom has detectable effects on tumor incidence nor, it seems, does the growth of an untransplanted tumor, either spontaneous or induced, immunize the host against the growth of a subsequent implant of that tumor. These observations suggest that even clearly immunogenic transplanted tumors may not have had their growths modulated by an immune reaction when they were as yet untransplanted in their primary hosts. Also, there are many data that have been interpreted to show that spontaneous tumors of rodents are, even when transplanted, nonimmunogenic. A reconsideration of the available studies, especially those in which either host immune capacity or tumor immunogenicity was titrated, has led me to different conclusions. I believe that the data suggest that probably all tumors, including spontaneous ones, are immunogenic but that the weak immune response in the primary host to the antigens of even the more immunogenic induced tumors usually produces stimulation of tumor growth rather than growth inhibition. The prevalence of immunogenicity suggests that vaccination or other forms of immunotherapy will eventually succeed; however, the analysis also suggests that, in the case of weakly immunogenic tumors, increasing the immune reaction, unless the increase is massive, may have little effect or may actually stimulate rather than inhibit the growths of these tumors in their primary hosts. Immunosuppression might actually be therapeutic in these cases; this may be an unrecognized benefit of the chemotherapy of many human tumors.

Entities:  

Mesh:

Year:  1994        PMID: 8313380

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Promotion of tumor invasion by cooperation of granulocytes and macrophages activated by anti-tumor antibodies.

Authors:  E Barbera-Guillem; K F May; J K Nyhus; M B Nelson
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer.

Authors:  Kenji Koishi; Reigetsu Yoshikawa; Tohru Tsujimura; Tomoko Hashimoto-Tamaoki; Syoudou Kojima; Hidenori Yanagi; Takehira Yamamura; Yoshinori Fujiwara
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

Review 3.  Immunotherapy III: Combinatorial molecular immunotherapy--a synthesis and suggestions.

Authors:  R G Vile; H Chong
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

4.  Metastatic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction.

Authors:  Z Chen; C W Smith; D Kiel; C Van Waes
Journal:  Clin Exp Metastasis       Date:  1997-09       Impact factor: 5.150

5.  The paradoxical effects of splenectomy on tumor growth.

Authors:  Richmond T Prehn
Journal:  Theor Biol Med Model       Date:  2006-06-26       Impact factor: 2.432

6.  T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role.

Authors:  G E Peoples; S Blotnick; K Takahashi; M R Freeman; M Klagsbrun; T J Eberlein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

7.  Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression.

Authors:  Maria Hedlund; Vered Padler-Karavani; Nissi M Varki; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

Review 8.  Immunoglobulin expression in non-lymphoid lineage and neoplastic cells.

Authors:  Zhengshan Chen; Xiaoyan Qiu; Jiang Gu
Journal:  Am J Pathol       Date:  2009-02-26       Impact factor: 4.307

9.  IgG expression in human colorectal cancer and its relationship to cancer cell behaviors.

Authors:  Na Niu; Jie Zhang; Tao Huang; Yingui Sun; Zhengshan Chen; Weining Yi; Christine Korteweg; Juping Wang; Jiang Gu
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

10.  Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma.

Authors:  Pei-Yu Liang; Hao-Yong Li; Zhi-Yan Zhou; Ying-Xia Jin; Sheng-Xing Wang; Xiao-Hui Peng; Shan-Ji Ou
Journal:  Tumour Biol       Date:  2013-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.